|
5ECH
Crystal Structure of FIN219-FIP1 complex with JA and ATP
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 B
1–217(217 aa)
链 C
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 2.14 Å
R-free 0.180
|
|
5ECH
Crystal Structure of FIN219-FIP1 complex with JA and ATP
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 E
1–217(217 aa)
链 F
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 2.14 Å
R-free 0.180
|
|
5ECK
Crystal Structure of FIN219-FIP1 complex with JA, Ile and ATP
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 B
1–217(217 aa)
链 C
1–217(217 aa)
|
未记录
|
ILE ISOLEUCINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.54 Å
R-free 0.175
|
|
5ECK
Crystal Structure of FIN219-FIP1 complex with JA, Ile and ATP
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 E
1–217(217 aa)
链 F
1–217(217 aa)
|
未记录
|
ILE ISOLEUCINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.54 Å
R-free 0.175
|
|
5ECL
Crystal Structure of FIN219-FIP1 complex with JA, Ile and Mg
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 B
1–217(217 aa)
链 C
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
ILE ISOLEUCINE × 1
MG MAGNESIUM ION × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.85 Å
R-free 0.219
|
|
5ECL
Crystal Structure of FIN219-FIP1 complex with JA, Ile and Mg
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 E
1–217(217 aa)
链 F
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
ILE ISOLEUCINE × 1
MG MAGNESIUM ION × 3
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.85 Å
R-free 0.219
|
|
5ECM
Crystal Structure of FIN219-FIP1 complex with JA and Leu
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 B
1–217(217 aa)
链 C
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
LEU LEUCINE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.60 Å
R-free 0.245
|
|
5ECM
Crystal Structure of FIN219-FIP1 complex with JA and Leu
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 E
1–217(217 aa)
链 F
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
LEU LEUCINE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.60 Å
R-free 0.245
|
|
5ECN
Crystal Structure of FIN219-FIP1 complex with JA, Leu and ATP
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 B
1–217(217 aa)
链 C
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
LEU LEUCINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.72 Å
R-free 0.188
|
|
5ECN
Crystal Structure of FIN219-FIP1 complex with JA, Leu and ATP
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 E
1–217(217 aa)
链 F
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
LEU LEUCINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.72 Å
R-free 0.188
|
|
5ECO
Crystal Structure of FIN219-FIP1 complex with JA, Leu and Mg
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 B
1–217(217 aa)
链 C
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
LEU LEUCINE × 1
MG MAGNESIUM ION × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.80 Å
R-free 0.239
|
|
5ECO
Crystal Structure of FIN219-FIP1 complex with JA, Leu and Mg
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 E
1–217(217 aa)
链 F
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
LEU LEUCINE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.80 Å
R-free 0.239
|
|
5ECP
Crystal Structure of FIN219-FIP1 complex with JA, MET and ATP
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 B
1–217(217 aa)
链 C
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
MET METHIONINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 2.25 Å
R-free 0.208
|
|
5ECP
Crystal Structure of FIN219-FIP1 complex with JA, MET and ATP
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 E
1–217(217 aa)
链 F
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
MET METHIONINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 2.25 Å
R-free 0.208
|
|
5ECQ
Crystal Structure of FIN219-FIP1 complex with JA, VAL and ATP
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 B
1–217(217 aa)
链 C
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
VAL VALINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.66 Å
R-free 0.234
|
|
5ECQ
Crystal Structure of FIN219-FIP1 complex with JA, VAL and ATP
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 E
1–217(217 aa)
链 F
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
VAL VALINE × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.66 Å
R-free 0.234
|
|
5ECR
Crystal Structure of FIN219-FIP1 complex with JA, VAL and Mg
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 B
1–217(217 aa)
链 C
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
VAL VALINE × 1
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.72 Å
R-free 0.281
|
|
5ECR
Crystal Structure of FIN219-FIP1 complex with JA, VAL and Mg
提交 2015-10-20
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 E
1–217(217 aa)
链 F
1–217(217 aa)
|
未记录
|
JAA {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid × 1
VAL VALINE × 1
GSH Glutathione × 2
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.72 Å
R-free 0.281
|
|
5ECS
Crystal Structure of FIP1 with GSH
提交 2015-10-20
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
1–217(217 aa)
|
未记录
|
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.65 Å
R-free 0.188
|
|
5ECS
Crystal Structure of FIP1 with GSH
提交 2015-10-20
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 2
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 B
1–217(217 aa)
|
未记录
|
GSH Glutathione × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;297 K;0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, 30%(w/v) PEG 3000
|
分辨率 1.65 Å
R-free 0.188
|